Sandoz announces positive results from Mylight Phase lll
Mylight study met its primary efficacy endpoint and showed no clinically meaningful differences to reference afliberceptResults offer hope of new...
Source: globenewswire.com
Stay updated with breaking news from Mylight Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mylight study met its primary efficacy endpoint and showed no clinically meaningful differences to reference afliberceptResults offer hope of new...
By Pierre Bertrand Novartis unit Sandoz said on Tuesday that its Mylight Phase III study assessing the efficacy of its biosimilar aflibercept drug met its primary endpoint. The Mylight... -Today at 01:57 am- MarketScreener